Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02766777 · ClinicalTrials.gov registry record · Phase 3
Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Phase 3 study, sponsored by Sucampo Pharma Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 87
- Enrollment target
NCT02766777 is a Phase 3 study that has completed, run by Sucampo Pharma Americas. The registered enrollment target is 87 participants.
The verdict
NCT02766777, a Phase 3 study, has completed, sponsored by Sucampo Pharma Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 87 participants
- Enrollment target
Study Summary
A study of the safety of lubiprostone in pediatric participants aged ≥ 6 Years to \< 18 years diagnosed with functional constipation.
Interventions
- DRUG Lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2016-04-12 |
| Est. Completion | 2016-11-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02766777
The ClinicalTrials.gov registry entry for NCT02766777 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sucampo Pharma Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lubiprostone is the first listed.
NCT02766777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02766777 about?
NCT02766777 is a clinical study titled "Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation". A study of the safety of lubiprostone in pediatric participants aged ≥ 6 Years to \< 18 years diagnosed with functional constipation.
What is the current status of trial NCT02766777?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 87 participants. The study started on 2016-04-12. Estimated completion is 2016-11-04.
What interventions are being tested in trial NCT02766777?
The interventions under investigation include: Lubiprostone (DRUG).
Who is sponsoring clinical trial NCT02766777?
This trial is sponsored by Sucampo Pharma Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.